Xylyx Bio

About:

Xylyx Bio creates effective science-based solutions for the benefit of human life and health.

Website: https://xylyxbio.com/

Twitter/X: xylyxbio

Top Investors: National Cancer Institute, National Institutes of Health, National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Boston Harbor Angels

Description:

Xylyx Bio creates effective science-based solutions for the benefit of human life and health. Xylyx Bio is a biomaterials pioneer, providing customers with products for research, clinical, and commercial applications. The company's solutions provide scientists engaged in pharmaceutical development, cell biology research, and regenerative medicine with the complete spectrum of components from the natural cell microenvironment required for precise and actionable results.

Total Funding Amount:

$7.13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Brooklyn, New York, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)xylyxbio.com

Founders:

John O'Neill

Number of Employees:

11-50

Last Funding Date:

2024-09-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai